agilon health (NYSE:AGL – Free Report) had its target price boosted by Barclays from $2.00 to $3.00 in a report published on Thursday morning,Benzinga reports. They currently have an underweight rating on the stock.
A number of other brokerages also recently issued reports on AGL. Royal Bank of Canada boosted their price objective on agilon health from $3.00 to $3.50 and gave the company an “outperform” rating in a research note on Wednesday, February 26th. TD Cowen boosted their price target on agilon health from $3.50 to $6.00 and gave the company a “hold” rating in a research note on Tuesday, April 15th. Sanford C. Bernstein raised shares of agilon health from a “market perform” rating to an “outperform” rating and raised their price objective for the stock from $3.30 to $8.50 in a research report on Tuesday, April 8th. Stifel Nicolaus boosted their target price on shares of agilon health from $2.00 to $3.00 and gave the company a “hold” rating in a research report on Wednesday, February 26th. Finally, Cowen restated a “hold” rating on shares of agilon health in a report on Tuesday, April 15th. Two equities research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat.com, agilon health currently has an average rating of “Hold” and a consensus price target of $4.89.
Get Our Latest Stock Analysis on AGL
agilon health Price Performance
agilon health (NYSE:AGL – Get Free Report) last posted its quarterly earnings data on Tuesday, May 6th. The company reported $0.03 EPS for the quarter, beating analysts’ consensus estimates of ($0.01) by $0.04. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. The company had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.50 billion. During the same period in the prior year, the firm posted ($0.02) EPS. The company’s quarterly revenue was down 4.5% on a year-over-year basis. As a group, research analysts expect that agilon health will post -0.59 EPS for the current year.
Institutional Investors Weigh In On agilon health
A number of institutional investors and hedge funds have recently bought and sold shares of AGL. JPMorgan Chase & Co. raised its holdings in shares of agilon health by 326.4% in the third quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company’s stock valued at $5,563,000 after purchasing an additional 1,083,492 shares during the last quarter. Inspire Investing LLC grew its position in agilon health by 106.6% in the 4th quarter. Inspire Investing LLC now owns 217,550 shares of the company’s stock worth $413,000 after purchasing an additional 112,241 shares in the last quarter. Cerity Partners LLC purchased a new stake in agilon health in the 4th quarter valued at about $34,000. Geode Capital Management LLC lifted its position in shares of agilon health by 0.5% during the 4th quarter. Geode Capital Management LLC now owns 6,928,724 shares of the company’s stock worth $13,168,000 after buying an additional 35,207 shares in the last quarter. Finally, MetLife Investment Management LLC boosted its stake in shares of agilon health by 4.0% in the 4th quarter. MetLife Investment Management LLC now owns 174,551 shares of the company’s stock worth $332,000 after buying an additional 6,762 shares during the last quarter.
agilon health Company Profile
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Featured Stories
- Five stocks we like better than agilon health
- Compound Interest and Why It Matters When Investing
- GlobalFoundries Stock Hits Bottom: Is a Rebound Coming?
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Here’s The Reason Goldman Sachs Is Bullish On MercadoLibre Stock
- Should You Invest in Penny Stocks?
- Analyst-Favorite Bitcoin Miner CleanSpark: Worth the Hype?
Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.